Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer.

Authors: Vareki SM, Chanyi RM, Abdur-Rashid K, Brennan L, Burton JP Abstract Precision medicine now needs to also consider the microbiome in oncology treatment. Ingested substances, whether they are a carcinogenic or therapeutic agent, will likely come into contact with the microbiota. Even those delivered extra-intestinally can be influenced beyond xenobiotic metabolism by biochemical factors associated with the microbiota or by an immunological predisposition created by the microbiome. We need to undertake one of the largest paradigm shifts to ever occur in medicine, that is, every drug or ingested substance needs to be re-evaluated for its pharmacological effect post-microbiome interaction. The importance of the microbiome with a focus on the treatment of cancer is discussed. In...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2zEFCxv